Haemonetics "Whole Blood" business Acquisition
Home
Corporate GVS Announces Strategic Acquisition of Haemonetics’ Whole Blood Business
-
Health & Safety
We promote Health and Safety in the most critical environments
Health is the priority to increase Safety for everyone -
Healthcare & Life Sciences
We bring innovation in Healthcare using Science
Healthcare and Life Sciences are the key for constant evolution
-
Energy & Mobility
We bridge reliability with tomorrow’s technology
Energy & Mobility for a Sustainable Future
-
-
ESG
COMPANYOur commitment to a Sustainable Future
-
GVS: IPO Ceremony at Borsa Italiana
CorporateWatch the video of a special moment: our debut on the Italian Stock Exchange!
News & media
-
GVS acquires 100% of the Italian Group Haemotronic
GVS has acquired the 100% of the share capital of the Italian Group Haemotronic. -
GVS refunds the original loan of 90 million Euros in advance
The Group will refund the residual amount of the loan stipulated in 2017 by 21 October 2020 -
GVS debuts on Borsa Italiana's MTA
First listing of the year on the Mercato Telematico Azionario (MTA) of the Italian Stock Exchange -
GVS acquires 100% of the RPB Group
GVS has acquired the 100% of the share capital of the RPB Group.
Divisions